Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.51−0.01 (-1.56%)
Close on Nov 18, 2026Market cap $14.02MP/E –Yield –
Citius Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Citius Pharmaceuticals's revenue for the twelve months ending Sep 30, 2022 was $90.00K, up 0.0% year over year. For fiscal 2022 it was $90.00K, up 0.0% from the year before. The highest annual figure on record is $90.00K in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $90.00K | 0.0% |
| FY2021 | Sep 30, 2021 | $90.00K | 0.0% |
| FY2020 | Sep 30, 2020 | $90.00K | 0.0% |
| FY2019 | Sep 30, 2019 | $90.00K | +20.0% |
| FY2018 | Sep 30, 2018 | $75.00K | +50.0% |
| FY2017 | Sep 30, 2017 | $50.00K | – |
| FY2012 | Sep 30, 2012 | $0 | – |
| FY2011 | Sep 30, 2011 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.49M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.67M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.94M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $0 | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $0 | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $0 | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $0 | – |
See a number that looks wrong?